Prevention and Control of Seasonal Influenza with Vaccines | Health Professionals | Seasonal Influenza (Flu)

Prevention and Control of Seasonal Influenza with Vaccines | Health Professionals | Seasonal Influenza (Flu)

Prevention and Control of Seasonal Influenza with Vaccines

Recommendations of the Advisory Committee on Immunization Practices—United States, 2015-16 Influenza Season

Updated information for the 2015–16 season includes 1) antigenic composition of U.S. seasonal influenza vaccines; 2) information on influenza vaccine products expected to be available for the 2015–16 season; 3) an updated algorithm for determining the appropriate number of doses for children aged 6 months through 8 years; and 4) recommendations for the use of live attenuated influenza vaccine (LAIV) and inactivated influenza vaccine (IIV) when either is available, including removal of the 2014–15 preferential recommendation for LAIV for healthy children aged 2 through 8 years.

Information regarding topics related to influenza vaccination that are not addressed in the 2015-16 report is available in the 2013 ACIP seasonal influenza recommendations.

Recommendations

• New! Groups Recommended for Vaccination and Timing of Vaccination
• Persons at Risk for Medical Complications Attributable to Severe Influenza
• Persons Who Live With or Care for Persons at Higher Risk for Influenza-Related Complications
• Pregnant Women
• New! Vaccine Dose Considerations for Children Aged 6 Months through 8 Years
  • New! FIGURE 1. Influenza vaccine dosing algorithm for children aged 6 months through 8 years
• New! Considerations for the Use of Live Attenuated Influenza Vaccine and Inactivated Influenza Vaccine when Either is Available and Appropriate
• New! Influenza Vaccination of Persons with a History of Egg Allergy
  • New! FIGURE 2. Recommendations regarding influenza vaccination of persons who report allergy to eggs
• New! Immunocompromised Persons
• Use of Influenza Antiviral Medications
• Concurrent Administration with Other Vaccines

Additional

• New! Vaccine Composition for the 2015-16 Season
• Background and Epidemiology

Available Vaccine Products and Indications

• New! Influenza Vaccines (Table 1), Contraindications and Precautions
• More on Approved Influenza Vaccine Products
• Dosage, Administration, and Storage of Influenza Vaccines

Influenza Vaccine Effectiveness

• Evaluating Influenza Vaccine Efficacy and Effectiveness Studies
• Immune Response Following Vaccination
• Duration of Immunity

Safety of Influenza Vaccines

• Inactivated Influenza Vaccines
• Live Attenuated Influenza Vaccines
• Recombinant Influenza Vaccine

Notes

• New! Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2015–16 Influenza Season, MMWR 2015, August 7, 2015 / 64(30);818-825
• Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP) — United States, 2014–15 Influenza Season, MMWR 2014, August 15, 2014 / 63(32);691-697
• Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices – United States, 2013-14, MMWR 2013, September 20, 2013 / 62(RR07);1-43